维普中文期刊产品整合服务
72篇 您的检索式:作者名="Peter PH"
    题名 作者 年代 出处 被引量
1Assessment of oxidative stress in chronic pancreatitis patients显示文摘AIM: To assess the levels of antioxidant capacity and oxidative damage in blood of chronic pancreatitis (CP) patients in comparison with those in healthy control sub- jects, by using several different analytical techniques. METHODS: Thirty-five CP patients and 35 healthy con- trol subjects were investigated prospectively with re- spect to plasma levels of thiols, ferric reducing ability of plasma (FRAP, i.e. antioxidant capacity), levels of protein carbonyls and thiobarbituric acid reactive substances (TBARS). Additionally, we evaluated the production of reactive oxygen species (ROS) in whole blood. RESULTS: The antioxidative thiols including cysteine, cysteinylglycine and glutathione were significantly lower in CP patients. In addition, the non-enzymatic antioxi- dant capacity was significantly lower in CP patients, which correlated with the amount of oxidative protein (protein carbonyls) and the extent of lipid damage (TBARS), both were significantly higher in CP patients. The ROS production in whole blood after stimulation with phorbol 12-myritate 13-acetaat, demonstrated a strong tendency to produce more ROS in CP patients. CONCLUSION: Oxidative stress may contribute to the pathogenesis of chronic pancreatitis by decreasing anti- oxidant capacity and increasing oxidative damage in CP patients may be a rationale for intervention with antioxi- dant therapy.Mariette Verlaan Hennie MJ Roelofs Annie van Schaik Geert JA Wanten Jan BMJ Jansen Wilbert HM Peters Joost PH Drenth 2006World Journal of Gastroenterology2006,12,35:3
2Mirizzi syndrome显示文摘Toscano RL Taylor PH Peters J 1994Am Surg1994,60,11:1
3Indications of nonlin- ear deterministic and finite - dimensional structures in time series of brain electrical activity: Dependence on recording region and brain state显示文摘Ralph G Andrzejak Klaus Lehnertz Florian Mormann Christo- ph Rieke Peter David Christian E Elger 2001Physical Review E2001,64,06:1
4The CD95 (APO21/ Fas) DISC and beyond 显示文摘Peter ME Krammer PH 2003Cell Death Differ2003,10,:1
5A meta analysis of treatment outcomes of early enteral versus early parenteral nutrition in hospitalized patients显示文摘Peter JV Moran JL Jennie PH 2005Crit Care Med2005,33,1:1
6A meta analysis of treatmentoutcomes of early enteral versus early parenteral nutrition inhospitalized patients显示文摘Peter JV Moran JL Jennie PH 2005Crit Care Med2005,33,:1
7Pyelitis in toxemias of pregnancy 显示文摘Peters JP Lavietes PH Zinnerman HM 1936AM J Obstet Gynecol1936,32,:1
8A meta analysis of treatment outeomes of early enteral versus early parenteral nutrition in hospitalized patients显示文摘Peter JV Moran JL Jennie PH 2005Crit Care Med2005,33,1:1
9The CD95 (AP0-1/Fas) DISC and beyond 显示文摘Peter ME Krammer PH 2003Cell Death Differ2003,10,1:1
10Mirizzi syndrome显示文摘Toscano RL Taylor PH Jr Peters J 1994Am Surg1994,60,11:1
11The CD95 (APO-1/Fas) DISC and beyond显示文摘Peter ME Krammer PH 2003Cell Death Differ2003,10,1:1
12A chamber to permit invasive manipulation of adherent cells in laminar flow with minimal disturbance of the flow field显示文摘Irena L Brian PH Peter FD 2000Annals of Biomedical Engineering2000,28,:1
13Design and num- berical implementation of a 3-D non-linear viscoelastic consti- tutive model for brain tissue during impact 显示文摘Brands DW Peters GW Bovendeerd PH 2004J Biomech2004,37,1:1
14The MRP4/ABCC4 geneencodes a novel apical organic anion transporter in human kidneyproximal tubules: putative efflux pump for urinary cAMP and cGMP显示文摘Van Aubel RA Smeets PH Peters JG 2002Am Soc Nephrol2002,13,3:1
15Regional and hormone-dependent effects of apolipopritein E genotype on changes in bone minend in perimenopausal women显示文摘Lars UG Peter V Anne PH 2001Bone Miner Res2001,,:1
16A metaanalysis of treatment outcomes of early enteral versus early parenteral nutrition inhospitalized patients显示文摘Peter JV Moran JL Jennie PH 2005Crit Care Med2005,33,:1
17The CD95 (APO-1/Fas) DISC and beyond显示文摘PETER ME KRAMMER PH 0,,01:1
18New transcranial Doppler index in infants with hydrocephalus:transsystolic time in clinical practice显示文摘Leliefeld PH Gooskens RH Peters RJ 2009Ultrasound Med Biol2009,35,10:1
19Labat法坐骨神经阻滞下局部麻醉药低容量高浓度较高容量低浓度更有效:一项前瞻性随机对照研究显示文摘背景有很多因素可以明显影响外周神经阻滞的起效时间和成功率,本项前瞻、随机、双盲研究比较了Labat后路法行坐骨神经阻滞时,单剂量的甲哌卡因300mg分别稀释至20和30ml注射后的阻滞效果差异。方法90例行足部手术的患者,随机分为2组接受坐骨神经阻滞,一组给予1.5%甲哌卡因20m1(45例),另一组给予1%甲哌卡因30m1(45例),所有阻滞均在神经刺激仪定位下进行(参数为刺激频率2Hz;刺激电流为1.5~0.5mA)。两组中,神经刺激反应在〈0.5mA时引出,亦可以定向诱发足部肌肉向跖侧屈曲,分别记录胫神经和腓总神经的运动感觉功能被阻滞的起效时间。而坐骨神经支配区域的针刺感觉消失,同时足部跖曲及背曲运动消失为阻滞成功的标准。结果用20ml的1.5%甲哌卡因组阻滞成功率(96.6%)显著高于30ml的1%甲哌卡因组(68.9%,P〈0.05)。而前者达到感觉与运动完全阻滞所需要的时间(11±6分钟,13±7分钟)也短于后者(17±8分钟,19±8分钟,P〈0.05)。结论Labat法行坐骨神经阻滞时,与高容量低浓度的局部麻醉药(1%甲哌卡因)比较,使用低容量高浓度的局部麻醉药(1.5%甲哌卡因)能够获得更高的阻滞成功率及更短的起效时间。Manuel Taboada Muniz, MD, PhD Jaime Rodriguez, MD, PhD Maria Bermudez, MD Cristina Valino, MD Noemi Blanco, MD Marcos Amor, MD Pilar, Aguirre, MD Ana Masid, MD Joaquin Cortes, MD, Ph Julian Alvarez, MD, PhD Peter G. Atanassoff, MD 杨光(译) 崔苏扬(校) 2010麻醉与镇痛2010,,2:1
20A meta analysis of treatment outcomes of early entcral versus early parenteral nutrition in hospitalized patients显示文摘Peter JV Moran JL Jennie PH 2005Crit Care Med2005,33,1:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费